Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.8931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von J Morel Symons und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized, Dermatologic Agents.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Symons, J. M., Breeze, J. L., Severtson, S. G., Weiss, S., & Patel, D. S. (2025). Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8931
Vancouver
Symons JM, Breeze JL, Severtson SG, Weiss S, Patel DS. Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.8931
BibTeX
@article{Symons2025,
author = {Symons, J Morel and Breeze, Janis L and Severtson, Stevan G and Weiss, Stefan and Patel, Dharm S},
title = {Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.8931}
}
EUVIMED